Samantha O Perakis (Samantha O Hasenleithner, Samantha Perakis, Samantha Hasenleithner)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Topics

Ultrasound Guided

Transcription Factor

Small Cell Lung Cancer

Circulating Tumor

Top Venues

NPJ precision oncology

Nature communications

JCO precision oncology

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Samantha O Perakis, Michael R Speicher
A clinician's handbook for using ctDNA throughout the patient journey. Molecular cancer 21 (1) (2022)
Denis Horgan, Tanja Čufer, Francesco Gatto, Iwona Lugowska, Donatella Verbanac, Ângela Carvalho, Jonathan A Lal, Marta Kozaric, Sinead Toomey, Hristo Y Ivanov, John Longshore, Umberto Malapelle, Samantha O Perakis, Paul Hofman, Catherine Alix-Panabières
Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring. Healthcare (Basel, Switzerland) 10 (9) (2022)
Sabrina Weber, Paul van der Leest, Hylke C Donker, Thomas Schlange, Hidde J Haisma, Menno Tamminga, Samantha O Perakis, Ricarda Graf, Tina Moser, Benjamin Spiegl, Marie-Laure Yaspo, Leon W M M Terstappen, Grigory A Sidorenkov, Thijo Jeroen N Hiltermann, Michael R Speicher, Ed M D Schuuring, Ellen Heitzer, Harry J M Groen
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. JCO precision oncology 5 (2022)
Jakob M Riedl, Samantha O Perakis, Gudrun Pregartner, Lukas Scheipner, Florian Posch, Karin Groller, Karl Kashofer, Stephan W Jahn, Thomas Bauernhofer, Martin Pichler, Herbert Stöger, Andrea Berghold, Gerald Hoefler, Michael R Speicher, Ellen Heitzer, Armin Gerger
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial. Therapeutic advances in medical oncology 13 (2021)
Sabrina Weber, Benjamin Spiegl, Samantha O Perakis, Christine M Ulz, Peter M Abuja, Karl Kashofer, Paul van der Leest, Maria Aguirre Azpurua, Menno Tamminga, Dan Brudzewsky, Dominic G Rothwell, Sumitra Mohan, Alexander Sartori, Rita Lampignano, Yves Konigshofer, Markus Sprenger-Haussels, Harriett Wikman, Inger R Bergheim, Vera Kloten, Ed M D Schuuring, Michael R Speicher, Ellen Heitzer
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling. Cancers 12 (6) (2020)
Tina Moser, Julie Waldispuehl-Geigl, Jelena Belic, Sabrina Weber, Qing Zhou, Samantha O Perakis, Ricarda Graf, Jasmin Alia Terzic, Florian Posch, Heinz Sill, Sigurd F Lax, Karl Kashofer, Gerald Hoefler, Helmut Schoellnast, Ellen Heitzer, Jochen B Geigl, Thomas Bauernhofer, Michael R Speicher
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer. NPJ precision oncology 4 (1) (2020)
Peter Ulz, Samantha O Perakis, Qing Zhou, Tina Moser, Jelena Belic, Isaac Lazzeri, Albert Wölfler, Armin Zebisch, Armin Gerger, Gunda Pristauz, Edgar Petru, Brandon White, Charles E S Roberts, John St John, Michael G Schimek, Jochen B Geigl, Thomas Bauernhofer, Heinz Sill, Christoph Bock, Ellen Heitzer, Michael R Speicher
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nature communications 11 (1) (2020)
Peter Ulz, Samantha O Perakis, Qing Zhou, Tina Moser, Jelena Belic, Isaac Lazzeri, Albert Wölfler, Armin Zebisch, Armin Gerger, Gunda Pristauz, Edgar Petru, Brandon White, Charles E S Roberts, John St John, Michael G Schimek, Jochen B Geigl, Thomas Bauernhofer, Heinz Sill, Christoph Bock, Ellen Heitzer, Michael R Speicher
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nature communications 10 (1) (2019)
Ellen Heitzer, Samantha O Perakis, Jochen B Geigl, Michael R Speicher
The potential of liquid biopsies for the early detection of cancer. NPJ precision oncology 1 (1) (2017)